Form cover
Page 1 of 9

Industry-academia collaborations survey

The purpose of this survey is to better understand how academics and research institutes collaborate with pharmaceutical companies.

The questions will explore the needs and expectations of scientific collaborators, success factors and challenges of working with pharmaceutical company partners, and effective ways for pharmaceutical companies to build awareness and communicate their capabilities to institutes.

We appreciate you taking the time to do this survey to help strengthen engagement and communications between academia and pharmaceutical companies and to improve the success of these collaborations.

The survey, delivered by Inpart and Norstella, has been commissioned by Daiichi Sankyo for market research purposes and is not intended to be promotional.

Your answers will be stored securely in accordance with GDPR and the results of the survey will be provided to Daiichi Sankyo anonymously.
For any questions about this survey, please contact [email protected]
https://storage.tally.so/c7dedc22-3b04-47f2-9d9f-924349d5e655/inpart-norstella.jpg

We will be sending a £20 Amazon voucher to the next 20 complete responses, please provide an email address if you would like to be included in this promotion. This will not affect the anonymity of your answers.

In which country are you employed?

In which country are you employed?
A
B
C
D
E

Which description from the list below best represents your current job role or responsibilities?

Which description from the list below best represents your current job role or responsibilities?
A
B
C
D
E
F
G
H

What best describes your current organization?

What best describes your current organization?
A
B
C
D

In your current job role, do you have direct experience in establishing, managing, and/or participating in collaborations between your organization and pharmaceutical companies?

In your current job role, do you have direct experience in establishing, managing, and/or participating in collaborations between your organization and pharmaceutical companies?
A
B